avrg: GSE58827: Dynamics of the Mouse Liver
Name | miRBASE accession |
---|---|
mmu-miR-155-5p
|
MIMAT0000165 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_-_18243289 Show fit | 2.49 |
ENSMUST00000035625.6
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
|
chr2_+_167688915 Show fit | 1.28 |
ENSMUST00000070642.3
|
CCAAT/enhancer binding protein (C/EBP), beta |
|
chr6_-_138043411 Show fit | 1.23 |
ENSMUST00000111873.1
|
solute carrier family 15, member 5 |
|
chr1_+_133363564 Show fit | 0.90 |
ENSMUST00000135222.2
|
ethanolamine kinase 2 |
|
chr4_+_97777606 Show fit | 0.84 |
ENSMUST00000075448.6
ENSMUST00000092532.6 |
nuclear factor I/A |
|
chr4_+_9844349 Show fit | 0.82 |
ENSMUST00000057613.2
|
growth differentiation factor 6 |
|
chr4_+_11156411 Show fit | 0.81 |
ENSMUST00000029865.3
|
transformation related protein 53 inducible nuclear protein 1 |
|
chr8_+_76899772 Show fit | 0.67 |
ENSMUST00000109913.2
|
nuclear receptor subfamily 3, group C, member 2 |
|
chr2_-_52676571 Show fit | 0.65 |
ENSMUST00000178799.1
|
calcium channel, voltage-dependent, beta 4 subunit |
|
chr5_-_66173051 Show fit | 0.65 |
ENSMUST00000113726.1
|
RNA binding motif protein 47 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.5 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.1 | 1.3 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 0.9 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.8 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.0 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.8 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.2 | 0.7 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.1 | 0.7 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 0.6 | GO:0061033 | secretion by lung epithelial cell involved in lung growth(GO:0061033) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.5 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.3 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.3 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.2 | GO:0060187 | cell pole(GO:0060187) |
0.0 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) SMAD2-SMAD3 protein complex(GO:0071144) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 1.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.2 | 0.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.8 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 0.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.0 | 0.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.5 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 0.9 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.7 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.3 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |